Kura Oncology, Inc. (KURA)
11.13
+0.79
(+7.64%)
USD |
NASDAQ |
May 21, 16:00
11.12
-0.01
(-0.09%)
After-Hours: 19:59
Kura Oncology Research and Development Expense (TTM) : 260.36M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Curis, Inc. | 26.16M |
| Novavax, Inc. | 345.26M |
| Capricor Therapeutics, Inc. | 91.90M |
| Agenus, Inc. | 69.64M |
| LadRx Corp. | 0.7712M |